🇺🇸 FDA
Patent

US 12343397

Drug-resistant immune cells and methods of use thereof

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12343397 (Drug-resistant immune cells and methods of use thereof) held by Regents of the University of Minnesota expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K31/436, A61K31/573